Zelig Eshhar

Cancer Breakthrough 20 Years in the Making

jhalper | September 12, 2011

Last month, Penn Medicine put out a press release heralding a "cancer treatment breakthrough 20 years in the making." In a small clinical trial, three patients with advanced chronic lymphocytic leukemia (CLL) were treated with genetically engineered versions of their own T cells. Just a few weeks after treatment the tumors had disappeared, and the patients remained in remission for a year before the study was published. The release didn't, however, explain those "20 years in the making." In 1989, Prof. Zelig Eshhar of the Weizmann Institute's Immunology Department first published a paper…

Advertisment

Donate

ScienceBlogs is where scientists communicate directly with the public. We are part of Science 2.0, a science education nonprofit operating under Section 501(c)(3) of the Internal Revenue Code. Please make a tax-deductible donation if you value independent science communication, collaboration, participation, and open access.

You can also shop using Amazon Smile and though you pay nothing more we get a tiny something.

Science 2.0

Science Codex

Glyphosate reduces soil biodiversity and decreases the proportion of native species (French)

Cancer Breakthrough 20 Years in the Making

Antarctica: Arrival

Looking at the Universe with PLANCK

California Newts